Medical device with predefined activated cellular integration
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C08G-063/00
C08G-063/02
출원번호
US-0807981
(2011-06-30)
등록번호
US-8865857
(2014-10-21)
국제출원번호
PCT/IB2011/002260
(2011-06-30)
§371/§102 date
20130215
(20130215)
국제공개번호
WO2012/001532
(2012-01-05)
발명자
/ 주소
Ladet, Sébastien
Gravagna, Philippe
출원인 / 주소
Sofradim Production
인용정보
피인용 횟수 :
0인용 특허 :
58
초록▼
A medical device includes a substrate having at least a portion thereof functionalized with at least one reactive member and a chemotactic agent functionalized with at least one complementary reactive member. The at least one reactive member and the at least one complementary reactive member are cov
A medical device includes a substrate having at least a portion thereof functionalized with at least one reactive member and a chemotactic agent functionalized with at least one complementary reactive member. The at least one reactive member and the at least one complementary reactive member are covalently bonded, adhering the chemotactic agent to the substrate.
대표청구항▼
1. A medical device comprising: a substrate having a surface functionalized with at least one click reactive member; anda chemotactic agent functionalized with at least one complementary click reactive member, wherein the at least one click reactive member and the at least one complementary click re
1. A medical device comprising: a substrate having a surface functionalized with at least one click reactive member; anda chemotactic agent functionalized with at least one complementary click reactive member, wherein the at least one click reactive member and the at least one complementary click reactive member are covalently bonded, adhering the chemotactic agent directly to the surface of the substrate, and the surface of the substrate promotes cellular integration. 2. The medical device according to claim 1, wherein the substrate is formed from a polymer selected from the group consisting of polycarbonates, polyolefins, polymethacrylates, polystyrenes, polyamides, polyurethanes, polyethylene terephthalate, poly (lactic acid), poly (glycolic acid), poly (hydroxbutyrate), dioxanones, δ-valerolactone, 1,dioxepanones, poly (phosphazine), polyesters, polyethylene glycol, polyethylene oxides, polyacrylamides, cellulose esters, fluoropolymers, vinyl polymers, silk, collagen, alginate, chitin, chitosan, hyaluronic acid, chondroitin sulfate, polyhydroxyethylmethylacrylate, polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, polyacetate, polycaprolactone, polypropylene, glycerols, poly(amino acids), copoly (ether-esters), polyalkylene oxalates, polyamides, poly (iminocarbonates), polyalkylene oxalates, polyoxaesters, polyorthoesters, polyphosphazenes, polypeptides and copolymers, block copolymers, homoploymers, blends and combinations thereof. 3. The medical device according to claim 1, wherein the at least one click reactive member and the at least one complementary click reactive member bind to one another via a reaction selected from the group consisting of Huisgen cycloaddition reaction, a Diels-Alder reaction and a thiol-ene reaction. 4. The medical device according to claim 3, wherein the Huisgen cycloaddition reaction includes an alkyne and an azide and is catalyzed by copper. 5. The medical device according to claim 3, wherein the Huisgen cycloaddition reaction involves a cyclooctyne reagent and an azide. 6. The medical device according to claim 3, wherein the at least one click reactive member and the at least one complementary click reactive member are thiols and alkenes. 7. The medical device according to claim 3, wherein the at least one click reactive member and the at least one complementary click reactive member are alkynes and azides. 8. The medical device according to claim 7, wherein the at least one click reactive member is an alkyne and the at least one complementary click reactive member is an azide. 9. The medical device according to claim 7, wherein the at least one click reactive member is an azide and the at least one complementary click reactive member is an alkyne. 10. The medical device according to claim 3, wherein the at least one click reactive member and the at least one complementary click reactive member are dienes and alkenes. 11. The medical device according to claim 1, wherein the substrate is selected from the group consisting of a mesh, a patch, a scaffold, a suture, a ligature, a sling, a pellicle, a film, a barrier, and a foam. 12. A method of manufacturing a medical device, the method comprising: functionalizing a substrate to form a plurality of click reactive members of a specific binding pair attached on a surface of the substrate;functionalizing at least one chemotactic agent to form a plurality of complementary click reactive members of the specific binding pair; andcontacting the substrate and the at least one chemotactic agent, wherein the plurality of click reactive members and the plurality of complementary click reactive member are covalently bonded, adhering the at least one chemotactic agent directly to the surface of the substrate, and the surface of the substrate promotes cellular integration. 13. The method according to claim 12, wherein the functionalizing of the substrate includes functionalizing the substrate with an azide. 14. The method according to claim 13, wherein the functionalizing of the at least one chemotactic agent includes functionalizing the at least one chemotactic agent with an alkyne. 15. A method of manufacturing a medical device, the method comprising: contacting a functionalized surface of a substrate with a plurality of click reactive members of a specific binding pair with at least one functionalized chemotactic agent with a plurality of complementary click reactive members of the specific binding pair, wherein the plurality of click reactive members and the plurality of complementary click reactive member are covalently bonded, adhering the at least one functionalized chemotactic agent directly to the functionalized surface of the substrate, and the surface of the substrate promotes cellular integration. 16. The method according to claim 15, further comprising functionalizing the substrate with an azide. 17. The method according to claim 16, further comprising functionalizing the at least one chemotactic agent with an alkyne. 18. The medical device according to claim 1, wherein the at least one chemotactic agent is selected from the group consisting of glycyl-histidyl-lysine, alanyl-glycyl-seryl-glutamine, f-methionyl-leucyl-phenylalanine, glycyl-histidyl-glycine, valinyl-glycyl-seryl-glutamine, and Tuftsin. 19. The method according to claim 12, wherein the at least one chemotactic agent is selected from the group consisting of glycyl-histidyl-lysine, alanyl-glycyl-seryl-glutamine, f-methionyl-leucyl-phenylalanine, glycyl-histidyl-glycine, valinyl-glycyl-seryl-glutamine, and Tuftsin. 20. The method according to claim 15, wherein the at least one functionalized chemotactic agent is selected from the group consisting of glycyl-histidyl-lysine, alanyl-glycyl-seryl-glutamine, f-methionyl-leucyl-phenylalanine, glycyl-histidyl-glycine, valinyl-glycyl-seryl-glutamine, and Tuftsin.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (58)
Paul O. Zamora ; Shigemasa Osaki ; Ray Tsang, Amphipathic coating for modulating cellular adhesion composition and methods.
Rowe Stephen C. (Wellesley MA) Hubbell Jeffrey A. (San Marino CA) Herman Stephen J. (Andover MA) Sun Vae (Palo Alto CA) Lang Michael F. (North Andover MA) Selecman George E. (Marblehead MA) Ahari Fre, Apparatus and method for local application of polymeric material to tissue.
Bennett Steven L. (Southington CT) Jiang Ying (North Haven CT) Gruskin Elliott A. (Killingworth CT) Connolly Kevin M. (Hamden CT), Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured theref.
Fran.cedilla.ois Regis Ory FR; Michel Therin FR; Philippe Gravagna FR; Jean-Louis Tayot FR, Composite prosthesis for preventing post-surgical adhesions and method for obtaining same.
Hubbell, Jeffrey A.; Elbert, Donald; Schoenmakers, Ronald, Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
Tomalia, Donald A.; Swanson, Douglas R.; Huang, Baohua; Pulgam, Veera Reddy, Dendritic polymers with enhanced amplification and interior functionality.
Tomalia, Donald A.; Swanson, Douglas R.; Huang, Baohua; Pulgam, Veera Reddy; Heinzelmann, Joseph R.; Svenson, Sonke; Reyna, Lori A.; Zhuravel, Michael A.; Chauhan, Abhay Singh; DeMattei, Cordell R., Dendritic polymers with enhanced amplification and interior functionality.
Spehar Edward R. (49 Orion Way Neshanic Station NJ 08853) Harkins Bernard F. (2000 Woodland Ave. S. Plainfield NJ 07080) Colin Laurence (Box 301 Cross River NY 10518), Dispensing mixer for the storage and mixing of separate materials.
Tiefenbrun Jonathan (62 Country Rd. Mamaronek NY 10543) Wilk Peter J. (185 W. End Ave. New York NY 10023), Instrument and associated method for applying biologically effective composition during laparoscopic operation.
Wolf Stephen J. (Hillsborough NJ) Mart Robert K. (Martinsville NJ) Otto Scott C. (Yardley PA), Locking holder for a pair of syringes and method of use.
Pittalis Francesco (Rome ITX) Bartoli Francesco (Rome ITX) Giovannoni Guido (S. Giuliano Milanese ITX), Process for the preparation of chitosan fibers.
Zuccato Alessandro,ITX ; Cella Gian Domenico,ITX ; Perego Gabriele,ITX, Process of surface activation of biocompatible and bioabsorbable aliphatic polyesters and polyesters thus activated.
Wallace Donald G. ; Cruise Gregory M. ; Rhee Woonza M. ; Schroeder Jacqueline Anne ; Coker ; III George T. ; Maroney Marcee M., Rapid gelling biocompatible polymer composition.
Wallace, Donald G.; Cruise, Gregory M.; Rhee, Woonza M.; Schroeder, Jacqueline Anne; Coker, III, George T.; Maroney, Marcee M.; Trollsas, Olof Mikael, Rapid-gelling biocompatible polymer composition and associated methods of preparation and use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.